TBLR1 and CREBBP as potential novel prognostic immunohistochemical biomarkers in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

TBLR1 and CREBBP as potential novel prognostic immunohistochemical biomarkers in diffuse large B-cell lymphoma

Published:2020-06-16 Issue:11 Volume:61 Page:2595-2604
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ednersson Susanne Bram¹²,Stern Mimmie³⁴,Fagman Henrik¹²,Nilsson-Ehle Herman⁴⁵,Hasselblom Sverker⁴⁶,Andersson Per-Ola³⁴

Affiliation:

1. Department of Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden

2. Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden

3. Department of Medicine, Section of Hematology, South Älvsborg Hospital, Borås, Sweden

4. Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden

5. Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden

6. Department of Research, Development & Education, Region Halland, Halmstad, Sweden

Funder

Borås Cancer Foundation

the Swedish State under the Agreement between the Swedish Government and the Country Councils

ALF-agreement

Lions Cancerfond Väst

Swedish Cancer Society

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1775216

Reference40 articles.

1. Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition. Lyon: International Agency for Research on Cancer; 2017.

2. Genetic heterogeneity of diffuse large B-cell lymphoma

3. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

4. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

5. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group;Cancer Genetics;2022-11

2. Prognostic values of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) expression in tissues of diffuse large B-cell non-Hodgkin lymphoma patients – an immunohistochemical study;Współczesna Onkologia;2022

3. Proteomic analysis in diffuse large B-cell lymphoma identifies dysregulated tumor microenvironment proteins in non-GCB/ABC subtype patients;Leukemia & Lymphoma;2021-06-11